AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Shattuck Labs, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00V776CR6
5.49▼ 0.11 (-1.96%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
5.60
Day's Range
5.36 – 5.60
52-Week Range
1.72 – 8.33
Volume
700.2K
Avg Volume
1.5M
Share Statistics
Shares Outstanding
Employees
40
Exchange
XNAS
Listed
2020-10-09
Share count as of August 7, 2026

Shattuck Labs, Inc. Common Stock (STTK) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Shattuck Labs, Inc. Common Stock (STTK)
What is Shattuck Labs, Inc. Common Stock's Market Cap?
Shattuck Labs, Inc. Common Stock's Market Cap is $551.0M, based on as-reported figures from SEC (XBRL) filings.
What is Shattuck Labs, Inc. Common Stock's Enterprise Value?
Shattuck Labs, Inc. Common Stock's Enterprise Value is $487.7M, based on as-reported figures from SEC (XBRL) filings.
What is Shattuck Labs, Inc. Common Stock's Price / Sales?
Shattuck Labs, Inc. Common Stock's Price / Sales is 551.0×, based on as-reported figures from SEC (XBRL) filings.
What is Shattuck Labs, Inc. Common Stock's EV / Revenue?
Shattuck Labs, Inc. Common Stock's EV / Revenue is 487.7×, based on as-reported figures from SEC (XBRL) filings.
What is Shattuck Labs, Inc. Common Stock's EV / EBITDA?
Shattuck Labs, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Shattuck Labs, Inc. Common Stock's Revenue (TTM)?
Shattuck Labs, Inc. Common Stock's Revenue (TTM) is $1.0M, based on as-reported figures from SEC (XBRL) filings.
What is Shattuck Labs, Inc. Common Stock's Net Income (TTM)?
Shattuck Labs, Inc. Common Stock's Net Income (TTM) is -$52.6M, based on as-reported figures from SEC (XBRL) filings.
What is Shattuck Labs, Inc. Common Stock's EBITDA?
Shattuck Labs, Inc. Common Stock's EBITDA is -$52.1M, based on as-reported figures from SEC (XBRL) filings.
What is Shattuck Labs, Inc. Common Stock's Diluted EPS (TTM)?
Shattuck Labs, Inc. Common Stock's Diluted EPS (TTM) is -0.52, based on as-reported figures from SEC (XBRL) filings.
What is Shattuck Labs, Inc. Common Stock's EBITDA Margin?
Shattuck Labs, Inc. Common Stock's EBITDA Margin is -5208.6%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · STTKAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth———-66.6%
Operating expenses:
Research and development
General and administrative
Expense from operations
% of revenue———1171.6%
Loss from operations
% of revenue———-1071.6%
Other income (expense)
Interest income——
Other expense
Total other income——
Net loss
% of revenue———-1005.6%
Net loss per share – basic (in dollars per share)
Net loss per share – diluted (in dollars per share)